Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06445400
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2024-05-31
Brief Title:
A Study of BL-M07D1 BL-M07D1Pertuzumab and BL-M07D1PertuzumabDocetaxel in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer
Sponsor:
Sichuan Baili Pharmaceutical Co Ltd
Organization:
Sichuan Baili Pharmaceutical Co Ltd
Organization Data
Organization:
Sichuan Baili Pharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
BL-M07D1-205
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sichuan Baili Pharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Baili-Bio Chengdu Pharmaceutical Co Ltd | INDUSTRY |